Drug shortage
Rocuronium Bromide Injection · Sandoz Inc.
FDA drug shortage · Current · updated Sep 18, 2026
Key facts
| Generic name | Rocuronium Bromide Injection |
|---|---|
| Company | Sandoz Inc. |
| Presentation | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95) |
| Dosage form | Injection |
| Status | Current |
| Therapeutic category | Anesthesia |
| Package NDCs | 0781-3220-95 |
| First posted | Feb 15, 2023 |
| Last updated | Sep 18, 2026 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: